Garde Capital, Inc. Novartis Ag Transaction History

Garde Capital, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $580,340 - $663,785	-7,705 Closed	0 $0
Q4 2018 Feb 20, 2019	SELL	$73.66 - $82.02 $736 - $820	-10 Reduced 0.13%	7,705 $661,000
Q3 2018 Nov 19, 2018	BUY	$66.94 - $77.43 $14,057 - $16,260	210 Added 2.8%	7,715 $673,000
Q2 2018 Aug 20, 2018	BUY	$64.91 - $73.36 $12,982 - $14,672	200 Added 2.74%	7,505 $567,000
Q1 2018 May 16, 2018	BUY	$70.39 - $84.15 $7,390 - $8,835	105 Added 1.46%	7,305 $591,000
Q3 2017 Nov 17, 2017	BUY	$74.14 - $77.27 $533,808 - $556,344	7,200	7,200 $618,000

1,426

138M

1.48M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Garde Capital, Inc. with notifications on news.